Breaking News Instant updates and real-time market news.

SBOW

SilverBow Resources

$3.82 /

-0.04 (-1.04%)

16:17
08/04/20
08/04
16:17
08/04/20
16:17

SilverBow Resources reports Q2 revenue $24.85M, consensus $31.3M

Reports Q2 EPS ($25.69). Reports net production averaged approximately 142 million cubic feet of natural gas equivalent per day. The company said, "Over the course of the second quarter, the SilverBow team was focused on production management, cost reduction initiatives and optimizing multiple playbooks for various commodity price scenarios. The second quarter will mark the low point in our production profile for 2020. Looking forward to the remainder of the year, we will be returning the remainder of our curtailed volumes to sales and are currently in the process of bringing online our inventory of drilled but uncompleted wells in the third quarter. Our plan is to restart our drilling program during the fourth quarter of 2020, targeting the development of our high rate of return gas projects. Over the next 18 months, our goal remains to maximize our free cash flow generation and protect our balance sheet. We are on track to achieve our stated objective of $40-$50 million of free cash flow for full year 2020, inclusive of the additional gas development expenditures we have allocated to our capital budget. The planned increase in capital expenditures in the fourth quarter of 2020 bolsters our preliminary 2021 free cash flow target of $20-$40 million at current strip prices, with potential tailwinds from higher gas prices this winter and through next year. Our visibility into cash flows over the near-term is supported by our hedged position on oil, which covers a substantial portion of our forecasted oil production through year-end 2021, as well as our gas hedging strategy, which has utilized a heavier weighting of two-way collars next year and intentionally preserves meaningful upside exposure to any improvement in 2021 gas strip from current levels. Additionally, at the midpoint of our production guidance, we would reach quarterly highs on our oil production combined with rising gas production rates as we exit the year. Moving into 2021, we have the flexibility to allocate capital across a well-balanced portfolio of gas and liquids development locations."

  • 05

    Aug

SBOW SilverBow Resources
$3.82 /

-0.04 (-1.04%)

05/14/20 Northland
Northland upgrades SilverBow to Outperform on natural gas shift
05/14/20 Northland
SilverBow Resources upgraded to Outperform from Market Perform at Northland
03/13/20 Northland
SilverBow Resources downgraded to Market Perform from Outperform at Northland

TODAY'S FREE FLY STORIES

Recommendations
General Electric price target raised to $9 from $6.81 at Deutsche Bank » 07:03
10/29/20
10/29
07:03
10/29/20
07:03
GE

General Electric

$7.43 /

+0.33 (+4.65%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GE General Electric
$7.43 /

+0.33 (+4.65%)

GE General Electric
$7.43 /

+0.33 (+4.65%)

10/13/20 Deutsche Bank
General Electric price target raised to $6.81 from $6.25 at Deutsche Bank
10/09/20 Goldman Sachs
Goldman sees 50% upside in General Electric, reinstates shares at Buy
09/17/20 JPMorgan
Those calling GE guidance 'inflection' misunderstand business, says JPMorgan
08/31/20 JPMorgan
JPMorgan's Tusa withdraws GE price target, sees fair value below $5
GE General Electric
$7.43 /

+0.33 (+4.65%)

GE General Electric
$7.43 /

+0.33 (+4.65%)

GE General Electric
$7.43 /

+0.33 (+4.65%)

GE General Electric
$7.43 /

+0.33 (+4.65%)

Hot Stocks
Evelo expects cash, cash equivalents to fund operations into 3Q21 » 07:02
10/29/20
10/29
07:02
10/29/20
07:02
EVLO

Evelo Biosciences

$4.55 /

-0.02 (-0.44%)

As of September 30, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
07/02/20 BMO Capital
Evelo Biosciences price target lowered to $17 from $21 at BMO Capital
05/21/20 Morgan Stanley
Morgan Stanley downgrades Evelo to Equal Weight after AD discontinuation
05/21/20 Morgan Stanley
Evelo Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

  • 25
    Jun
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

Upgrade
Best Buy upgraded to Hold from Sell at R5 Capital » 07:02
10/29/20
10/29
07:02
10/29/20
07:02
BBY

Best Buy

$111.01 /

-2.435 (-2.15%)

R5 Capital analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBY Best Buy
$111.01 /

-2.435 (-2.15%)

BBY Best Buy
$111.01 /

-2.435 (-2.15%)

06:59 Today R5 Capital
Correction: Best Buy, not Bed Bath & Beyond upgraded at R5 Capital
10/28/20 Piper Sandler
Piper calls Best Buy a favorite idea after 'very favorable' checks
10/23/20 Oppenheimer
Best Buy downgraded to Perform from Outperform at Oppenheimer
10/23/20 Oppenheimer
Best Buy downgraded to Perform from Outperform at Oppenheimer
BBY Best Buy
$111.01 /

-2.435 (-2.15%)

BBY Best Buy
$111.01 /

-2.435 (-2.15%)

BBY Best Buy
$111.01 /

-2.435 (-2.15%)

BBY Best Buy
$111.01 /

-2.435 (-2.15%)

Earnings
Evelo Biosciences reports Q3 EPS (45c), consensus (50c) » 07:02
10/29/20
10/29
07:02
10/29/20
07:02
EVLO

Evelo Biosciences

$4.55 /

-0.02 (-0.44%)

"We can reduce…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
07/02/20 BMO Capital
Evelo Biosciences price target lowered to $17 from $21 at BMO Capital
05/21/20 Morgan Stanley
Morgan Stanley downgrades Evelo to Equal Weight after AD discontinuation
05/21/20 Morgan Stanley
Evelo Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

  • 25
    Jun
EVLO Evelo Biosciences
$4.55 /

-0.02 (-0.44%)

Recommendations
PPD price target raised to $38 from $33 at Deutsche Bank » 07:02
10/29/20
10/29
07:02
10/29/20
07:02
PPD

PPD

$33.18 /

-0.83 (-2.44%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPD PPD
$33.18 /

-0.83 (-2.44%)

PPD PPD
$33.18 /

-0.83 (-2.44%)

10/12/20 Truist
PPD, Inc. initiated with a Buy at Truist
09/22/20 Mizuho
PPD, Inc. price target raised to $38 from $35 at Mizuho
09/21/20 Baird
PPD, Inc. price target raised to $40 from $36 at Baird
08/06/20 Mizuho
PPD, Inc. price target raised to $35 from $29 at Mizuho
PPD PPD
$33.18 /

-0.83 (-2.44%)

  • 17
    Sep
  • 06
    Feb
PPD PPD
$33.18 /

-0.83 (-2.44%)

Earnings
1-800-Flowers.com sees Q2 adjusted EPS growth 18%-23% y-o-y, consensus $1.31 » 07:02
10/29/20
10/29
07:02
10/29/20
07:02
FLWS

1-800-Flowers.com

$25.23 /

-0.59 (-2.29%)

Sees Q2 revenue growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLWS 1-800-Flowers.com
$25.23 /

-0.59 (-2.29%)

FLWS 1-800-Flowers.com
$25.23 /

-0.59 (-2.29%)

08/28/20
Fly Intel: Top five analyst upgrades
08/28/20 DA Davidson
1-800-Flowers.com upgraded to Neutral from Underperform at DA Davidson
08/28/20 DA Davidson
1-800-Flowers.com upgraded to Neutral from Underperform at DA Davidson
08/25/20 DA Davidson
DA Davidson keeps 'priced to perfection' 1-800-Flowers.com at Underperform
FLWS 1-800-Flowers.com
$25.23 /

-0.59 (-2.29%)

FLWS 1-800-Flowers.com
$25.23 /

-0.59 (-2.29%)

Earnings
International Paper reports Q3 adjusted EPS 71c, consensus 48c » 07:01
10/29/20
10/29
07:01
10/29/20
07:01
IP

International Paper

$42.97 /

-1.41 (-3.18%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IP International Paper
$42.97 /

-1.41 (-3.18%)

10/11/20 BMO Capital
International Paper upgraded to Outperform from Market Perform at BMO Capital
10/09/20
Fly Intel: Top five analyst upgrades
10/09/20 Wells Fargo
International Paper upgraded to Overweight from Equal Weight at Wells Fargo
10/09/20 Wells Fargo
International Paper upgraded to Overweight from Equal Weight at Wells Fargo
IP International Paper
$42.97 /

-1.41 (-3.18%)

IP International Paper
$42.97 /

-1.41 (-3.18%)

IP International Paper
$42.97 /

-1.41 (-3.18%)

Recommendations
Teladoc price target raised to $244 from $239 at Deutsche Bank » 07:01
10/29/20
10/29
07:01
10/29/20
07:01
TDOC

Teladoc

$227.00 /

+4.42 (+1.99%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

10/28/20 Piper Sandler
Livongo Health downgraded to Neutral from Overweight at Piper Sandler
10/28/20 Piper Sandler
Teladoc price target raised to $305 from $232 at Piper Sandler
10/14/20 JPMorgan
Livongo Health downgraded to Neutral from Overweight at JPMorgan
09/23/20 Piper Sandler
Amazon Care program expansion not a threat to Teladoc, says Piper Sandler
TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

TDOC Teladoc
$227.00 /

+4.42 (+1.99%)

Recommendations
Bed Bath & Beyond weakness a buying opportunity, says Baird » 07:01
10/29/20
10/29
07:01
10/29/20
07:01
BBBY

Bed Bath & Beyond

$21.10 /

-2.91 (-12.12%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBBY Bed Bath & Beyond
$21.10 /

-2.91 (-12.12%)

BBBY Bed Bath & Beyond
$21.10 /

-2.91 (-12.12%)

06:59 Today R5 Capital
Correction: Best Buy, not Bed Bath & Beyond upgraded at R5 Capital
06:35 Today Morgan Stanley
Morgan Stanley ups Bed Bath & Beyond to Equal Weight, quadruples target to $24
06:32 Today Morgan Stanley
Bed Bath & Beyond upgraded to Equal Weight from Underweight at Morgan Stanley
06:05 Today Telsey Advisory
Bed Bath & Beyond upgraded to Outperform from Market Perform at Telsey Advisory
BBBY Bed Bath & Beyond
$21.10 /

-2.91 (-12.12%)

BBBY Bed Bath & Beyond
$21.10 /

-2.91 (-12.12%)

BBBY Bed Bath & Beyond
$21.10 /

-2.91 (-12.12%)

BBBY Bed Bath & Beyond
$21.10 /

-2.91 (-12.12%)

Recommendations
CME Group price target lowered to $167 from $181 at Deutsche Bank » 07:00
10/29/20
10/29
07:00
10/29/20
07:00
CME

CME Group

$149.56 /

-9.81 (-6.16%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CME CME Group
$149.56 /

-9.81 (-6.16%)

CME CME Group
$149.56 /

-9.81 (-6.16%)

09/23/20 Atlantic Equities
CME Group upgraded to Overweight from Neutral at Atlantic Equities
09/11/20 Loop Capital
Loop Capital initiates exchanges, market-structure names w/ fintech focus
09/11/20 Loop Capital
CME Group initiated with a Sell at Loop Capital
07/30/20 Deutsche Bank
CME Group price target lowered to $178 from $196 at Deutsche Bank
CME CME Group
$149.56 /

-9.81 (-6.16%)

CME CME Group
$149.56 /

-9.81 (-6.16%)

CME CME Group
$149.56 /

-9.81 (-6.16%)

CME CME Group
$149.56 /

-9.81 (-6.16%)

Earnings
A.O. Smith raises FY20 adj. EPS view to $1.95-$1.98 from $1.72-$1.86 » 07:00
10/29/20
10/29
07:00
10/29/20
07:00
AOS

A.O. Smith

$51.26 /

-1.51 (-2.86%)

Consensus $1.87."We…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AOS A.O. Smith
$51.26 /

-1.51 (-2.86%)

AOS A.O. Smith
$51.26 /

-1.51 (-2.86%)

10/23/20 Citi
A.O. Smith initiated with a Neutral at Citi
10/13/20 UBS
A.O. Smith downgraded to Neutral from Buy at UBS
10/13/20 UBS
A.O. Smith downgraded to Neutral from Buy at UBS
09/17/20
Fly Intel: Top five analyst upgrades
AOS A.O. Smith
$51.26 /

-1.51 (-2.86%)

Earnings
1-800-Flowers.com reports Q1 adjusted EPS (10c), consensus (13c) » 07:00
10/29/20
10/29
07:00
10/29/20
07:00
FLWS

1-800-Flowers.com

$25.23 /

-0.59 (-2.29%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLWS 1-800-Flowers.com
$25.23 /

-0.59 (-2.29%)

FLWS 1-800-Flowers.com
$25.23 /

-0.59 (-2.29%)

08/28/20
Fly Intel: Top five analyst upgrades
08/28/20 DA Davidson
1-800-Flowers.com upgraded to Neutral from Underperform at DA Davidson
08/28/20 DA Davidson
1-800-Flowers.com upgraded to Neutral from Underperform at DA Davidson
08/25/20 DA Davidson
DA Davidson keeps 'priced to perfection' 1-800-Flowers.com at Underperform
FLWS 1-800-Flowers.com
$25.23 /

-0.59 (-2.29%)

FLWS 1-800-Flowers.com
$25.23 /

-0.59 (-2.29%)

Recommendations
Markel price target raised to $1,100 from $925 at Deutsche Bank » 07:00
10/29/20
10/29
07:00
10/29/20
07:00
MKL

Markel

$941.12 /

-29.62 (-3.05%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MKL Markel
$941.12 /

-29.62 (-3.05%)

MKL Markel
$941.12 /

-29.62 (-3.05%)

07/30/20 Deutsche Bank
Markel price target raised to $925 from $895 at Deutsche Bank
04/08/20 RBC Capital
Markel price target lowered to $1,250 from $1,500 at RBC Capital
12/05/19 RBC Capital
Markel upgraded to Outperform from Sector Perform at RBC Capital
MKL Markel
$941.12 /

-29.62 (-3.05%)

Recommendations
Masco price target raised to $67 from $60 at RBC Capital » 07:00
10/29/20
10/29
07:00
10/29/20
07:00
MAS

Masco

$53.77 /

+0.185 (+0.35%)

RBC Capital analyst Mike…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAS Masco
$53.77 /

+0.185 (+0.35%)

09/30/20
Fly Intel: Top five analyst downgrades
09/30/20 Goldman Sachs
Masco downgraded to Neutral from Buy at Goldman Sachs
09/22/20 Deutsche Bank
Installed Building price target raised to $110 from $93 at Deutsche Bank
07/31/20 Deutsche Bank
Masco price target raised to $64 from $54 at Deutsche Bank
MAS Masco
$53.77 /

+0.185 (+0.35%)

MAS Masco
$53.77 /

+0.185 (+0.35%)

MAS Masco
$53.77 /

+0.185 (+0.35%)

Recommendations
Wyndham Destinations price target raised to $41 from $38 at Deutsche Bank » 06:59
10/29/20
10/29
06:59
10/29/20
06:59
WYND

Wyndham Destinations

$31.71 /

-1.85 (-5.51%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WYND Wyndham Destinations
$31.71 /

-1.85 (-5.51%)

WYND Wyndham Destinations
$31.71 /

-1.85 (-5.51%)

10/13/20 JPMorgan
Wyndham Destinations price target raised to $40 from $32 at JPMorgan
09/08/20 Goldman Sachs
Wyndham Destinations upgraded to Buy from Neutral at Goldman Sachs
07/21/20 Deutsche Bank
Wyndham Destinations price target raised to $38 from $34 at Deutsche Bank
07/14/20 JPMorgan
Too early to turn bullish on Lodging stocks, says JPMorgan
WYND Wyndham Destinations
$31.71 /

-1.85 (-5.51%)

Earnings
A.O. Smith reports Q3 adj. EPS 66c, consensus 52c » 06:59
10/29/20
10/29
06:59
10/29/20
06:59
AOS

A.O. Smith

$51.26 /

-1.51 (-2.86%)

Reports Q3 revenue $760M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AOS A.O. Smith
$51.26 /

-1.51 (-2.86%)

AOS A.O. Smith
$51.26 /

-1.51 (-2.86%)

10/23/20 Citi
A.O. Smith initiated with a Neutral at Citi
10/13/20 UBS
A.O. Smith downgraded to Neutral from Buy at UBS
10/13/20 UBS
A.O. Smith downgraded to Neutral from Buy at UBS
09/17/20
Fly Intel: Top five analyst upgrades
AOS A.O. Smith
$51.26 /

-1.51 (-2.86%)

Recommendations
Ashford Hospitality price target lowered to $6 from $11 at Deutsche Bank » 06:58
10/29/20
10/29
06:58
10/29/20
06:58
AHT

Ashford Hospitality

$1.39 /

-0.08 (-5.46%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AHT Ashford Hospitality
$1.39 /

-0.08 (-5.46%)

AHT Ashford Hospitality
$1.39 /

-0.08 (-5.46%)

06/17/20
Fly Intel: Top five analyst upgrades
06/17/20 DA Davidson
Ashford Hospitality upgraded to Neutral from Underperform at DA Davidson
04/06/20 B. Riley FBR
Ashford Hospitality downgraded to Neutral from Buy at B. Riley FBR
03/10/20 DA Davidson
Ashford Hospitality downgraded to Underperform from Neutral at DA Davidson
AHT Ashford Hospitality
$1.39 /

-0.08 (-5.46%)

AHT Ashford Hospitality
$1.39 /

-0.08 (-5.46%)

Earnings
Xylem sees Q4 organic revenue down 6%-8%, consensus $1.29B » 06:58
10/29/20
10/29
06:58
10/29/20
06:58
XYL

Xylem

$87.41 /

-1.6 (-1.80%)

Sees Q4 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XYL Xylem
$87.41 /

-1.6 (-1.80%)

XYL Xylem
$87.41 /

-1.6 (-1.80%)

07/15/20 Rosenblatt
Xylem upgraded to Buy water business resilience at Rosenblatt
07/14/20 Rosenblatt
Xylem upgraded to Buy from Neutral at Rosenblatt
06/04/20 Rosenblatt
Xylem price target raised to $70 from $63 at Rosenblatt
05/15/20 Vertical Research
Xylem upgraded to Hold from Sell at Vertical Research
XYL Xylem
$87.41 /

-1.6 (-1.80%)

XYL Xylem
$87.41 /

-1.6 (-1.80%)

Earnings
Columbus McKinnon sees Q3 revenue $150M-$160M, consensus $162.88M » 06:57
10/29/20
10/29
06:57
10/29/20
06:57
CMCO

Columbus McKinnon

$34.47 /

-0.89 (-2.52%)

Total backlog has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMCO Columbus McKinnon
$34.47 /

-0.89 (-2.52%)

CMCO Columbus McKinnon
$34.47 /

-0.89 (-2.52%)

08/28/20 Barrington
Columbus McKinnon price target raised to $41 from $38 at Barrington
07/31/20 Sidoti
Columbus McKinnon upgraded to Buy after earnings at Sidoti
07/31/20 Sidoti
Columbus McKinnon upgraded to Buy from Neutral at Sidoti
07/30/20 Barrington
Columbus McKinnon price target raised to $38 from $36 at Barrington
CMCO Columbus McKinnon
$34.47 /

-0.89 (-2.52%)

Recommendations
Dine Brands price target raised to $54 from $45 at Deutsche Bank » 06:57
10/29/20
10/29
06:57
10/29/20
06:57
DIN

Dine Brands

$55.98 /

-0.66 (-1.17%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIN Dine Brands
$55.98 /

-0.66 (-1.17%)

DIN Dine Brands
$55.98 /

-0.66 (-1.17%)

10/14/20 Wedbush
Dine Brands price target raised to $70 from $55 at Wedbush
10/14/20 Wedbush
Dine Brands price target raised to $70 from $55 at Wedbush
07/30/20 Wedbush
Dine Brands price target raised to $55 from $50 at Wedbush
07/30/20 Deutsche Bank
Dine Brands price target raised to $45 from $40 at Deutsche Bank
DIN Dine Brands
$55.98 /

-0.66 (-1.17%)

DIN Dine Brands
$55.98 /

-0.66 (-1.17%)

Earnings
Xylem reports Q3 adjusted EPS 62c, consensus 51c » 06:56
10/29/20
10/29
06:56
10/29/20
06:56
XYL

Xylem

$87.41 /

-1.6 (-1.80%)

Reports Q3 revenue $1.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XYL Xylem
$87.41 /

-1.6 (-1.80%)

XYL Xylem
$87.41 /

-1.6 (-1.80%)

07/15/20 Rosenblatt
Xylem upgraded to Buy water business resilience at Rosenblatt
07/14/20 Rosenblatt
Xylem upgraded to Buy from Neutral at Rosenblatt
06/04/20 Rosenblatt
Xylem price target raised to $70 from $63 at Rosenblatt
05/15/20 Vertical Research
Xylem upgraded to Hold from Sell at Vertical Research
XYL Xylem
$87.41 /

-1.6 (-1.80%)

XYL Xylem
$87.41 /

-1.6 (-1.80%)

Recommendations
Fortune Brands price target raised to $85 from $77 at RBC Capital » 06:56
10/29/20
10/29
06:56
10/29/20
06:56
FBHS

Fortune Brands

$81.53 /

-0.24 (-0.29%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FBHS Fortune Brands
$81.53 /

-0.24 (-0.29%)

FBHS Fortune Brands
$81.53 /

-0.24 (-0.29%)

09/22/20 Deutsche Bank
Installed Building price target raised to $110 from $93 at Deutsche Bank
09/10/20 KeyBanc
Fortune Brands upgraded to Overweight with $95 target at KeyBanc
09/10/20 KeyBanc
Fortune Brands upgraded to Overweight from Sector Weight at KeyBanc
08/04/20 Loop Capital
American Woodmark price target raised to $97 from $79 at Loop Capital
FBHS Fortune Brands
$81.53 /

-0.24 (-0.29%)

FBHS Fortune Brands
$81.53 /

-0.24 (-0.29%)

FBHS Fortune Brands
$81.53 /

-0.24 (-0.29%)

Earnings
Columbus McKinnon reports Q2 EPS (17c), consensus 23c » 06:56
10/29/20
10/29
06:56
10/29/20
06:56
CMCO

Columbus McKinnon

$34.47 /

-0.89 (-2.52%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMCO Columbus McKinnon
$34.47 /

-0.89 (-2.52%)

CMCO Columbus McKinnon
$34.47 /

-0.89 (-2.52%)

08/28/20 Barrington
Columbus McKinnon price target raised to $41 from $38 at Barrington
07/31/20 Sidoti
Columbus McKinnon upgraded to Buy after earnings at Sidoti
07/31/20 Sidoti
Columbus McKinnon upgraded to Buy from Neutral at Sidoti
07/30/20 Barrington
Columbus McKinnon price target raised to $38 from $36 at Barrington
CMCO Columbus McKinnon
$34.47 /

-0.89 (-2.52%)

Recommendations
UPS price target raised to $201 from $195 at Deutsche Bank » 06:56
10/29/20
10/29
06:56
10/29/20
06:56
UPS

UPS

$155.75 /

-15.38 (-8.99%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UPS UPS
$155.75 /

-15.38 (-8.99%)

UPS UPS
$155.75 /

-15.38 (-8.99%)

06:36 Today Barclays
UPS price target lowered to $145 from $160 at Barclays
10/27/20 UBS
UPS upgraded to Buy from Neutral at UBS
10/21/20 Oppenheimer
UPS price target raised to $186 from $153 at Oppenheimer
10/16/20 Barclays
UPS price target raised to $160 from $135 at Barclays
UPS UPS
$155.75 /

-15.38 (-8.99%)

UPS UPS
$155.75 /

-15.38 (-8.99%)

UPS UPS
$155.75 /

-15.38 (-8.99%)

UPS UPS
$155.75 /

-15.38 (-8.99%)

Earnings
Aptiv sees FY20 adj. EPS $1.65-$1.80, consensus $1.28 » 06:55
10/29/20
10/29
06:55
10/29/20
06:55
APTV

Aptiv

$93.44 /

-2.85 (-2.96%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APTV Aptiv
$93.44 /

-2.85 (-2.96%)

10/22/20 JPMorgan
Aptiv price target raised to $109 from $89 at JPMorgan
10/22/20 Barclays
Aptiv price target raised to $112 from $90 at Barclays
10/19/20 Baird
Aptiv reinstated with an Outperform at Baird
10/15/20 Jefferies
Aptiv price target raised to $113 from $96 at Jefferies
APTV Aptiv
$93.44 /

-2.85 (-2.96%)

  • 10
    Jun
APTV Aptiv
$93.44 /

-2.85 (-2.96%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.